Cyclerion Therapeutics (CYCN) EPS (Basic) (2018 - 2025)
Cyclerion Therapeutics (CYCN) posted EPS (Basic) of -$0.31 for Q3 2025, up 42.71% on a QoQ basis from -$0.54 in Q2 2025, and up 30.15% year-over-year from -$0.24 in Q3 2024.
Powered by 
Analysis
Cyclerion Therapeutics (CYCN) EPS (Basic) (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics has reported EPS (Basic) for 8 years, with the latest figure at -$0.31 in Q3 2025.
- On a quarterly basis, EPS (Basic) rose 30.15% year-over-year to -$0.31 in Q3 2025; TTM through Sep 2025 was -$1.13, a 51.97% increase from a year earlier, with the FY2024 full-year figure at -$1.44, up 40.07% from the prior year.
- EPS (Basic) was -$0.31 for Q3 2025 at Cyclerion Therapeutics, up from -$0.54 in the prior quarter.
- The five-year high for EPS (Basic) was $3.06 in Q3 2023, with the low at -$9.06 in Q2 2021.
- Average EPS (Basic) over 5 years is -$2.92, with a median of -$1.86 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 162.78% in 2023, then tumbled 114.58% in 2024.
- Over 5 years, EPS (Basic) stood at -$7.33 in 2021, then surged by 53.84% to -$3.38 in 2022, then soared by 77.3% to -$0.77 in 2023, then soared by 125.97% to $0.2 in 2024, then sank by 256.47% to -$0.31 in 2025.
- The last three EPS (Basic) figures came in at -$0.31 (Q3 2025), -$0.54 (Q2 2025), and -$0.57 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.35 Bn | 192.36 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.10 Bn | 176.92 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.31 Bn | 123.46 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.56 Bn | 55.38 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.68 Bn | 48.54 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.44 Bn | 30.14 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.80 Bn | 30.52 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn | -0.40 |
| 10 | Cyclerion Therapeutics | 15.70 Mn | 12.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.54 |
| Mar 31, 2025 | -0.57 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | -0.45 |
| Jun 30, 2024 | -0.55 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.77 |
| Sep 30, 2023 | 3.06 |
| Jun 30, 2023 | -1.86 |
| Mar 31, 2023 | -3.24 |
| Dec 31, 2022 | -3.38 |
| Sep 30, 2022 | -4.88 |
| Jun 30, 2022 | -6.18 |
| Mar 31, 2022 | -5.98 |
| Dec 31, 2021 | -7.33 |
| Sep 30, 2021 | -5.21 |
| Jun 30, 2021 | -9.06 |
| Mar 31, 2021 | -7.86 |
| Dec 31, 2020 | -12.65 |